Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma

Hypertension

Volumn 65, Issue 3, 2015, Pages 622-628

  Zheng, Fang Fang ^a,b   Zhu, Li Min ^a   Nie, Ai Fang ^a   Li, Xiao Ying ^a   Lin, Jing Rong ^b   Zhang, Ke ^b   Chen, Jing ^a   Zhou, Wen Long ^a   Shen, Zhou Jun ^a   Zhu, Yi Chun ^c   Wang, Ji Guang ^a   Zhu, Ding Liang ^a   Gao, Ping Jin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Chinese Academy of Sciences   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

aldosterone; hypertension; KCNJ5; potassium channel; somatic mutation

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ALDOSTERONE SYNTHASE; ATP2B3 PROTEIN; ATPA1 PROTEIN; CACNA1D PROTEIN; CALCIUM ION; INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN; MESSENGER RNA; POTASSIUM ION; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL; ATP1A1 PROTEIN, HUMAN; ATP2B3 PROTEIN, HUMAN; CACNA1D PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; KCNJ5 PROTEIN, HUMAN; PLASMA MEMBRANE CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; POTASSIUM;

ADULT; ALDOSTERONE RELEASE; ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MEMBRANE DEPOLARIZATION; MIDDLE AGED; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; UPREGULATION; WESTERN BLOTTING; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREVALENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; TUMOR VOLUME;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; ALDOSTERONE; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CALCIUM CHANNELS, L-TYPE; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHENOTYPE; PLASMA MEMBRANE CALCIUM-TRANSPORTING ATPASES; POTASSIUM; PREVALENCE; RETROSPECTIVE STUDIES; SEX FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TUMOR BURDEN;

EID: 84924271392     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.03346     Document Type: Article

References (31)

1. Rossi GP, Bernini G, Caliumi C, et al.; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300. doi: 10.1016/j.jacc.2006.07.059.
2. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M; Participants of the German Conn's Registry. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab. 2009;94:1125-1130. doi: 10.1210/jc.2008-2116.
3. Savard S, Amar L, Plouin PF, Steichen O. Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension. 2013;62:331-336. doi: 10.1161/HYPERTENSIONAHA.113.01060.
4. Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98:4826-4833. doi: 10.1210/jc.2013-2805.
5. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80-85. doi: 10.1001/archinternmed.2007.33.
6. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281. doi: 10.1210/jc.2008-0104.
7. Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA. Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol. 2013;9:104-112. doi: 10.1038/nrendo.2012.230.
8. Rossi GP, Cesari M, Cuspidi C, Maiolino G, Cicala MV, Bisogni V, Mantero F, Pessina AC. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism. Hypertension. 2013;62:62-69. doi: 10.1161/HYPERTENSIONAHA.113.01316.
9. Choi M, Scholl UI, Yue P, et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772. doi: 10.1126/science.1198785.
10. Beuschlein F, Boulkroun S, Osswald A, et al. Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet. 2013;45:440-444, 444e1. doi: 10.1038/ng.2550.
11. Scholl UI, Goh G, Stölting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050-1054. doi: 10.1038/ng.2695.
12. Azizan EA, Poulsen H, Tuluc P, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nat Genet. 2013;45:1055-1060. doi: 10.1038/ng.2716.
13. Boulkroun S, Beuschlein F, Rossi GP, et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension. 2012;59:592-598. doi: 10.1161/HYPERTENSIONAHA.111.186478.
14. Taguchi R, Yamada M, Nakajima Y, Satoh T, Hashimoto K, Shibusawa N, Ozawa A, Okada S, Rokutanda N, Takata D, Koibuchi Y, Horiguchi J, Oyama T, Takeyoshi I, Mori M. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab. 2012;97:1311-1319. doi: 10.1210/jc.2011-2885.
15. Rossi GP, Cesari M, Letizia C, Seccia TM, Cicala MV, Zinnamosca L, Kuppusamy M, Mareso S, Sciomer S, Iacobone M, Mantero F, Pessina AC. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens. 2014;32:1514-1521; discussion 1522. doi: 10.1097/HJH.0000000000000186.
16. Arnesen T, Glomnes N, Strømsøy S, Knappskog S, Heie A, Akslen LA, Grytaas M, Varhaug JE, Gimm O, Brauckhoff M. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway. Langenbecks Arch Surg. 2013;398:869-874. doi: 10.1007/s00423-013-1093-2.
17. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A; Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009. Endocr J. 2011;58:711-721.
18. Azizan EA, Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, Brown MJ, O'Shaughnessy KM. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension. 2012;59:587-591. doi: 10.1161/HYPERTENSIONAHA.111.186239.
19. Monticone S, Hattangady NG, Nishimoto K, et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab. 2012;97:E1567-E1572. doi: 10.1210/jc.2011-3132.
20. Åkerström T, Crona J, Delgado Verdugo A, et al. Comprehensive resequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS One. 2012;7:e41926. doi: 10.1371/journal.pone.0041926.
21. Fernandes-Rosa FL, Williams TA, Riester A, et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension. 2014;64:354-361. doi: 10.1161/HYPERTENSIONAHA.114.03419.
22. Seccia TM, Mantero F, Letizia C, Kuppusamy M, Caroccia B, Barisa M, Cicala MV, Miotto D, Rossi GP. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. J Clin Endocrinol Metab. 2012;97:E2307-E2313. doi: 10.1210/jc.2012-2342.
23. Williams TA, Monticone S, Schack VR, et al. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension. 2014;63:188-195. doi: 10.1161/HYPERTENSIONAHA.113.01733.
24. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology. 2012;153:1774-1782. doi: 10.1210/en.2011-1733.
25. Kuppusamy M, Caroccia B, Stindl J, Bandulik S, Lenzini L, Gioco F, Fishman V, Zanotti G, Gomez-Sanchez C, Bader M, Warth R, Rossi GP. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium. J Clin Endocrinol Metab. 2014;99:E1765-E1773. doi: 10.1210/jc.2014-1927.
26. Bettahi I, Marker CL, Roman MI, Wickman K. Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. J Biol Chem. 2002;277:48282-48288. doi: 10.1074/jbc.M209599200.
27. Mulatero P, Tauber P, Zennaro MC, et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism. Hypertension. 2012;59:235-240. doi: 10.1161/ HYPERTENSIONAHA.111.183996.
28. Scholl UI, Nelson-Williams C, Yue P, Grekin R, Wyatt RJ, Dillon MJ, Couch R, Hammer LK, Harley FL, Farhi A, Wang WH, Lifton RP. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A. 2012;109:2533-2538. doi: 10.1073/pnas.1121407109.
29. Murthy M, Azizan EA, Brown MJ, O'Shaughnessy KM. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma. J Hypertens. 2012;30:1827-1833. doi: 10.1097/HJH.0b013e328356139f.
30. Cheng CJ, Sung CC, Wu ST, Lin YC, Sytwu HK, Huang CL, Lin SH. Novel KCNJ5 Mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance. J Clin Endocrinol Metab. 2015;100:E155-E163. doi: 10.1210/jc.2014-3009.
31. Dekkers T, ter Meer M, Lenders JW, Hermus AR, Schultze Kool L, Langenhuijsen JF, Nishimoto K, Ogishima T, Mukai K, Azizan EA, Tops B, Deinum J, Küsters B. Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit? J Clin Endocrinol Metab. 2014;99:E1341-E1351. doi: 10.1210/jc.2013-4255.